My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

2.800 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
MarketBeat Week in Review – 03/03 - 03/07
Stocks had another down week despite a mostly benign jobs report; and with the latest reads on inflation coming next week the uncertainty may continue 
Via MarketBeat
Topics Economy
Missed the Hims & Hers Rally? Clover Health Could Be Next
After a steep decline from its all-time high prices, shares of Hims & Hers are now recovering to show investor interest in the space. 
Via MarketBeat
Earnings Scheduled For February 27, 2025
 
Via Benzinga
(CLOV) - Analyzing Clover Health Investments's Short Interest
 
Via Benzinga
How Is The Market Feeling About Clover Health Investments?
 
Via Benzinga
Looking Into Clover Health Investments's Recent Short Interest
 
Via Benzinga
Nvidia, Tesla Lead Tech Stock Rebound: What's Driving Markets Friday?
Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA) 
Via Benzinga
Clover Health (NASDAQ:CLOV) Reports Sales Below Analyst Estimates In Q4 Earnings
Health insurance company Clover Health (NASDAQ:CLOV) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was... 
Via StockStory
Trump's Tariffs, Potential 'Stagflation': What's Driving Markets Thursday?
The S&P 500 and Nasdaq both slipped into the red, reversing early gains on Thursday, while the Dow Jones remained in positive territory in midday trading. 
Via Benzinga
Topics Government Stocks
How Is The Market Feeling About Clover Health Investments?
 
Via Benzinga
What To Expect From Clover Health’s (CLOV) Q4 Earnings
Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow afternoon. Here’s what to look for. 
Via StockStory
Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc.
Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in. 
Via Benzinga
Topics Stocks
Ten Young Ones
Here are a variety of lesser-known charts from my “Recents” watch list. Quite a few of them look like good bullish plays. 
Via Talk Markets
Topics Stocks / Equities
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:CLOV) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence Fraud
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential
From FN Media Group LLC
Via GlobeNewswire
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says. 
Via Benzinga
Why Clover Health (CLOV) Stock Is Rising
Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025. 
Via Benzinga
Nvidia, Palantir, Clover Health, Joby Aviation, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. indices closed Wednesday in positive territory, with the Dow Jones Industrial Average increasing by 0.09% to 42,196.52. 
Via Benzinga
Topics Stocks
Clover Health Stock Surges Over 29% On High Volume: Recap
Clover Health Investments shares are trading higher Wednesday amid increased trading volume and gaining traction across social media platforms. Here's what you need to know. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
RPM International Posts Upbeat Earnings, Joins Joby Aviation, Ciena And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Hindenburg Research Issued a Scathing Short Report on Super Micro Computer. This Is What Happened to 3 Other Big Stocks It Targeted.
Short reports can be crippling for a stock in the short term, but what about the longer run? 
Via The Motley Fool
What's Going On With Clover Health Shares Wednesday?
Clover Health stock is moving higher Wednesday after the company's subsidiary, Counterpart Health, announced a multi-year agreement with Iowa Clinic. 
Via Benzinga
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Clover Health Stock Is Climbing After The Close: What's Going On?
Clover Health Investments Corp shares are trading higher in extended trading Tuesday after one of the company's subsidiaries announced a multi-year agreement with The Iowa Clinic. 
Via Benzinga
PVH, nCino, Marathon Digital And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.